James L. Mohler, MD, on Prostate Cancer: Management Approaches

NCCN 2018 Annual Conference
Tweet this page

James L. Mohler, MD, of Roswell Park Cancer Institute, discusses personalized medicine, molecular risk stratification, and better androgen-deprivation therapy for men with prostate cancer.

Jun

Today In Oncology

AMA Rejects Recommendation to Reaffirm Opposition to Medical Aid in Dying

Male Thyroid Cancer Survivors Face 50% Higher Risk of Cardiovascular Disease Than Women

Prophylactic Cranial Irradiation in Stage III NSCLC

Low-Fat Dietary Intervention and Overall Survival After Breast Cancer Diagnosis

Informed Consent Issues for Patients With Advanced Cancer in Phase I Trials

;